Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Grifols S.A. (GRFS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 15,288,340
  • Shares Outstanding, K 682,820
  • Annual Sales, $ 4,881 M
  • Annual Income, $ 749,050 K
  • 36-Month Beta 1.19
  • Price/Sales 3.13
  • Price/Cash Flow 15.45
  • Price/Book 3.72

Price Performance

See More
Period Period Low Period High Performance
1-Month
20.13 +9.99%
on 05/01/18
23.14 -4.32%
on 05/14/18
+1.98 (+9.82%)
since 04/25/18
3-Month
20.07 +10.31%
on 04/06/18
23.14 -4.32%
on 05/14/18
-0.63 (-2.77%)
since 02/23/18
52-Week
19.92 +11.14%
on 07/27/17
25.18 -12.07%
on 01/23/18
+0.73 (+3.41%)
since 05/25/17

Most Recent Stories

More News
Grifols Expands its Blood Typing Solutions Portfolio in the United States with Antisera Reagents

Grifols (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS), a leading global producer of plasma-derived medicines and a leader in the development of innovative diagnostic solutions, today announced the expansion...

GRFS : 22.14 (-1.12%)
GRF : 7.42 (+0.13%)
Report: Exploring Fundamental Drivers Behind Itau Unibanco Holding S.A, Weibo, Redhill Biopharma, Shenandoah Telecommunications, Grifols, S.A, and Orthofix International N.V -- New Horizons, Emerging Trends, and Upcoming Developments

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Itau Unibanco Holding S.A....

RDHL : 7.09 (-0.28%)
OFIX : 54.40 (-0.16%)
SHEN : 30.25 (-1.31%)
GRFS : 22.14 (-1.12%)
ITUB : 12.24 (-1.61%)
WB : 102.57 (+0.17%)
Grifols 2017 Annual Report on Form 20-F filed with the SEC on April 6, 2018

Grifols, S.A. ("Grifols") (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS) announced that it has filed its 2017 Annual Report on Form 20-F with the United States Securities and Exchange Commission ("SEC") on April...

GRFS : 22.14 (-1.12%)
GRF : 7.42 (+0.13%)
Consolidated Research: 2018 Summary Expectations for B Communications, Student Transportation, Aurinia Pharmaceuticals, Grifols, S.A., NEXEO SOLUTIONS, and ASML Holding N.V. -- Fundamental Analysis, Key Performance Indications

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of B Communications Ltd. (NASDAQ:BCOM),...

BCOM : 10.48 (+4.49%)
STB : 7.50 (unch)
NXEO : 9.59 (-0.83%)
AUPH : 5.84 (unch)
NXEOU : 10.50 (+1.45%)
GRFS : 22.14 (-1.12%)
ASML : 201.10 (+0.13%)
Henry Schien to Distribute Grifols Product in United States

We expect Henry Schien's (HSIC) partnership with Grifols to be strategically accretive to its portfolio given the rising demand for saline products in U.S. market.

HSIC : 70.43 (-0.11%)
BIO : 287.93 (-0.39%)
GRFS : 22.14 (-1.12%)
PKI : 74.32 (-1.72%)
Grifols Shines Light on Rare Disease with Launch of Educational Campaign "Look Into Genetic COPD"

Grifols (MCE:GRF, MCE:GRF.P, and NASDAQ:GRFS), a leader in the production of plasma-derived medicines and in diagnostic and hospital solutions to improve people's health, is drawing attention to a rare...

GRFS : 22.14 (-1.12%)
GRF : 7.42 (+0.13%)
Technical Perspectives on Biotech Stocks -- Grifols, Heat Biologics, Hemispherx Biopharma, and iBio

WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on GRFS, HTBX, HEB, and IBIO which can be accessed for free by signing up to www.wallstequities.com/registration....

HTBX : 2.25 (+2.27%)
GRFS : 22.14 (-1.12%)
Grifols Misterium® Cleanroom Solutions Expands to Include Revolutionary Decontamination Air and Surface Disinfection Systems for Pharmaceutical Preparation

-- Grifols is the exclusive U.S. distributor for the airinspace portfolio of solutions to control contamination in existing cleanrooms, segregated compounding areas, and temporary cleanrooms

GRFS : 22.14 (-1.12%)
GRF : 7.42 (+0.13%)
Quotidian Technical Highlights on Selected Biotech Stocks -- Advaxis, Grifols, Juno Therapeutics, and Lexicon Pharma

In keeping with the commitment to dynamically provide members with timely information WallStEquities.com has issued free tailored Stock Review on ADXS, GRFS, JUNO, and LXRX which is a click away at http://www.wallstequities.com/registration....

ADXS : 1.80 (-1.64%)
LXRX : 9.61 (+2.13%)
GRFS : 22.14 (-1.12%)
JUNO : 86.96 (+0.10%)
Breakfast Technical Briefing on Biotech Stocks -- Coherus Biosciences, Exelixis, Geron, and Grifols

If you want a Stock Review on CHRS, EXEL, GERN, or GRFS then come over to http://dailystocktracker.com/register/ and sign up for your free customized report. Investor's Business Daily reported that 35...

CHRS : 15.30 (-1.92%)
GRFS : 22.14 (-1.12%)
EXEL : 20.84 (+1.66%)
GERN : 4.70 (-2.49%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum. Long term indicators fully support a continuation of the trend.

See More Share

Trade GRFS with:

Business Summary

Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous therapy, clinical nutrition, diagnostic and hospital logistics systems. The Company operates its business through three divisions: Bioscience...

See More

Key Turning Points

2nd Resistance Point 22.57
1st Resistance Point 22.35
Last Price 22.14
1st Support Level 21.76
2nd Support Level 21.39

See More

52-Week High 25.18
Fibonacci 61.8% 23.17
Fibonacci 50% 22.55
Last Price 22.14
Fibonacci 38.2% 21.93
52-Week Low 19.92

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar